Original language | English |
---|---|
Pages (from-to) | 781-783 |
Number of pages | 3 |
Journal | Internal Medicine Journal |
Volume | 50 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Jul 2020 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Formation of the Australia and New Zealand Vasculitis Society to improve the care of patients with Vasculitis in Australian and New Zealand. / Ryan, Jessica; Tieu, Joanna; Bose, Bhadran et al.
In: Internal Medicine Journal, Vol. 50, No. 7, 01.07.2020, p. 781-783.Research output: Contribution to journal › Editorial › Other › peer-review
TY - JOUR
T1 - Formation of the Australia and New Zealand Vasculitis Society to improve the care of patients with Vasculitis in Australian and New Zealand
AU - Ryan, Jessica
AU - Tieu, Joanna
AU - Bose, Bhadran
AU - Francis, Ross
AU - Gingold, Michael
AU - Goh, Liang
AU - Gray, James
AU - Hill, Catherine L.
AU - Hissaria, Pravin
AU - Jahan, Sadia
AU - Langguth, Daman
AU - Li, Jennifer
AU - McLean-Tooke, Andrew
AU - Peh, Chen A.
AU - Rahman, Mukhlesur
AU - Sammel, Tony
AU - Stamp, Lisa K.
AU - Street, Mark
AU - Swaminathan, Sanjay
AU - Wong, Nikki L.
AU - Kitching, Richard
N1 - Funding Information: There have been significant contributions from Australia and New Zealand in several international, multicentre investigator‐led clinical trials of AAV. These include PEXIVAS, by far the largest randomised trial to date in AAV, which included 704 patients of which 104 were from Australia and New Zealand. This was made possible with support from the Australasian Kidney Trials Network and National Health and Medical Research Council (NHMRC) funding. Other major AAV trials with significant Australia and New Zealand contributions include RITUXVAS, MYCYC, RITAZAREM and the industry‐led ADVOCATE study. Several of these trials have led to changes in clinical practice and substantial improvements in outcomes for patients with AAV. Close links with international groups such as the European Vasculitis Society, Vasculitis Clinical Research Consortium and research centres in Cambridge and Oxford provide optimism for future collaborative research. 15 16–18 Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/7/1
Y1 - 2020/7/1
UR - http://www.scopus.com/inward/record.url?scp=85087788173&partnerID=8YFLogxK
U2 - 10.1111/imj.14898
DO - 10.1111/imj.14898
M3 - Editorial
C2 - 32656978
AN - SCOPUS:85087788173
VL - 50
SP - 781
EP - 783
JO - Internal Medicine Journal
JF - Internal Medicine Journal
SN - 1444-0903
IS - 7
ER -